Furthermore, the expression of negative regulators of CFH, specifically CFHR1, CFHR3, and CFHR4, is predicted to be upregulated in AMD cases, which consequently should lead to an increased complement activation. This evidence concerns the gene CFHR1 and age-related macular degeneration.